Table A6.
Placebo | OnabotA 240 U |
OnabotA 360 U |
p-Values OnabotA 240 U vs. Placebo |
p-Values OnabotA 360 U vs. Placebo |
|
---|---|---|---|---|---|
Elbow | (n = 45) | (n = 51) | (n = 51) | ||
Baseline | 2.76 | 2.47 | 2.57 | 0.131 | 0.301 |
Week 1 | −0.24 | −0.53 | −0.62 | 0.016 | 0.013 |
Week 6 | −0.47 | −0.60 | −0.89 | 0.358 | 0.018 |
Week 12 | −0.26 | −0.40 | −0.51 | 0.474 | 0.100 |
Week 18 | −0.46 | −0.51 | −0.80 | 0.969 | 0.058 |
Week 24 | −0.57 | −0.42 | −0.68 | 0.207 | 0.534 |
Week 30 | −0.24 | −0.40 | −0.56 | 0.608 | 0.112 |
Wrist | (n = 47) | (n = 52) | (n = 54) | ||
Baseline | 2.60 | 2.29 | 2.61 | 0.089 | 0.843 |
Week 1 | −0.21 | −0.60 | −0.80 | 0.008 | <0.001 |
Week 6 | −0.35 | −0.79 | −1.19 | 0.011 | <0.001 |
Week 12 | −0.12 | −0.43 | −0.60 | 0.094 | 0.006 |
Week 18 | −0.35 | −0.54 | −0.96 | 0.181 | <0.001 |
Week 24 | −0.36 | −0.49 | −0.86 | 0.455 | 0.010 |
Week 30 | −0.34 | −0.44 | −0.49 | 0.602 | 0.476 |
Fingers | (n = 46) | (n = 49) | (n = 55) | ||
Baseline | 2.80 | 2.47 | 2.40 | 0.060 | 0.018 |
Week 1 | −0.48 | −0.61 | −0.49 | 0.369 | 0.970 |
Week 6 | −0.44 | −0.80 | −0.81 | 0.062 | 0.029 |
Week 12 | −0.34 | −0.66 | −0.28 | 0.060 | 0.700 |
Week 18 | −0.41 | −0.69 | −0.62 | 0.164 | 0.132 |
Week 24 | −0.48 | −0.56 | −0.29 | 0.818 | 0.200 |
Week 30 | −0.36 | −0.42 | −0.11 | 0.809 | 0.124 |
Thumb | (n = 35) | (n = 36) | (n = 35) | ||
Baseline | 2.37 | 2.00 | 1.94 | 0.102 | 0.096 |
Week 1 | −0.23 | −0.61 | −0.43 | 0.071 | 0.547 |
Week 6 | −0.35 | −0.67 | −0.63 | 0.213 | 0.285 |
Week 12 | −0.29 | −0.49 | −0.30 | 0.249 | 0.897 |
Week 18 | −0.38 | −0.65 | −0.72 | 0.162 | 0.149 |
Week 24 | −0.49 | −0.69 | −0.42 | 0.639 | 0.568 |
Week 30 | −0.29 | −0.54 | −0.10 | 0.246 | 0.559 |